Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema

ClinicalTrials.gov ID: NCT05897424

Public ClinicalTrials.gov record NCT05897424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema

Study identification

NCT ID
NCT05897424
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
185 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2024 (Actual)
Primary completion
Jun 30, 2028 (Estimated)
Completion
Sep 30, 2028 (Estimated)
Last update posted
Apr 13, 2026

2024 – 2028

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
UAB Lung Health Center- Site Number : 105 Birmingham Alabama 35205-2610 —
St Joseph's Hospital and Medical Center- Site Number : 126 Phoenix Arizona 85013-4220 —
David Geffen School of Medicine at UCLA- Site Number : 124 Los Angeles California 90095-3075 —
University of California Davis Medical Center- Site Number : 110 Sacramento California 95817-2201 —
National Jewish Medical and Research Center- Site Number : 123 Denver Colorado 80206-2761 —
Nuvance Health Medical Practices, Pulmonary & Sleep Specialists- Site Number : 119 Danbury Connecticut 06810-5038 —
University of Florida - Gainesville - 1600 SW Archer Rd- Site Number : 101 Gainesville Florida 32610-3003 —
Indiana University- Site Number : 127 Indianapolis Indiana 46202-5128 —
Brigham and Women's Hospital -75 Francis Street- Site Number : 131 Boston Massachusetts 02115-6105 —
University of Minnesota-420 Delaware Str SE- Site Number : 125 Minneapolis Minnesota 55455-0341 —
Hannibal Regional Healthcare System-HRMG-Hannibal- Site Number : 111 Hannibal Missouri 63401-6890 —
Columbia University Irving Medical Center- Site Number : 104 New York New York 10032-3729 —
Oregon Health and Science University- Site Number : 117 Portland Oregon 97239-3011 —
Penn State Health Milton S. Hershey Medical Center- Site Number : 122 Hershey Pennsylvania 17033-2360 —
Temple University Hospital - 3401 N Broad St- Site Number : 130 Philadelphia Pennsylvania 19140-5103 —
Velocity Clinical Research - Spartanburg - PPDS- Site Number : 120 Spartanburg South Carolina 29303-4225 —
Houston Methodist Hospital- Site Number : 113 Houston Texas 77030-2703 —
University of Utah Health Care- Site Number : 106 Salt Lake City Utah 84132-0001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05897424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05897424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →